Consolidated Planning Corp’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Consolidated Planning Corp's LLY Position: Q3 2026 in Review
Consolidated Planning Corp increased its Eli Lilly (LLY) stake by 17% in Q3 2026, buying an estimated $253K and bringing the position to 1,475 shares worth $1.71M. The position accounts for 0.23% of the portfolio, ranked #66.
Consolidated Planning Corp first reported a position in LLY in Q3 2021 and has held it in 15 quarters since. The position peaked at $4.65M in Q3 2024. 2,688 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Consolidated Planning Corp held 1,475 shares of Eli Lilly worth $1.71M as of Q3 2026.
- Consolidated Planning Corp bought 214 Eli Lilly shares in Q3 2026, an estimated $253K.
- Eli Lilly made up 0.23% of Consolidated Planning Corp's portfolio in Q3 2026, its #66 holding.
- Consolidated Planning Corp first reported a position in Eli Lilly in Q3 2021 and has held it in 15 quarters since.
- Consolidated Planning Corp's Eli Lilly position peaked at $4.65M in Q3 2024.
- 2,688 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Consolidated Planning Corp's 13F filing for Q3 2026, filed 21 Oct 2026.